Clinical Trial: Construction of a Postoperative Recurrence Prediction Model for Papillary Thyroid Carcinoma Based on cfDNA Multi-Modal Biomarkers and Random Forest Algorithm: A Multicenter Clinical Study (China)

Posted On: 2026-10-12

China, Oct. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a Postoperative Recurrence Prediction Model for Papillary Thyroid Carcinoma Based on cfDNA Multi-Modal Biomarkers and Random Forest Algorithm: A Multicenter Clinical Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133961

Registration Time: 2026/10/09

Type: Observational study

Primary Sponsor: Langzhong People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340306

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Construction of a Postoperative Recurrence Prediction Model for Papillary Thyroid Carcinoma Based on cfDNA Multi-Modal Biomarkers and Random Forest Algorithm: A Multicenter Clinical Study (China)